Literature DB >> 24589342

Advances in basic and clinical immunology in 2013.

Javier Chinen1, Luigi D Notarangelo2, William T Shearer3.   

Abstract

A significant number of contributions to our understanding of primary immunodeficiencies (PIDs) in pathogenesis, diagnosis, and treatment were published in the Journal in 2013. For example, deficiency of mast cell degranulation caused by signal transducer and activator of transcription 3 deficiency was demonstrated to contribute to the difference in the frequency of severe allergic reactions in patients with autosomal dominant hyper-IgE syndrome compared with that seen in atopic subjects with similar high IgE serum levels. High levels of nonglycosylated IgA were found in patients with Wiskott-Aldrich syndrome, and these abnormal antibodies might contribute to the nephropathy seen in these patients. New described genes causing immunodeficiency included caspase recruitment domain 11 (CARD11), mucosa-associated lymphoid tissue 1 (MALT1) for combined immunodeficiencies, and tetratricopeptide repeat domain 7A (TTC7A) for mutations associated with multiple atresia with combined immunodeficiency. Other observations expand the spectrum of clinical presentation of specific gene defects (eg, adult-onset idiopathic T-cell lymphopenia and early-onset autoimmunity might be due to hypomorphic mutations of the recombination-activating genes). Newborn screening in California established the incidence of severe combined immunodeficiency at 1 in 66,250 live births. The use of hematopoietic stem cell transplantation for PIDs was reviewed, with recommendations to give priority to research oriented to establish the best regimens to improve the safety and efficacy of bone marrow transplantation. These represent only a fraction of significant research done in patients with PIDs that has accelerated the quality of care of these patients. Genetic analysis of patients has demonstrated multiple phenotypic expressions of immune deficiency in patients with nearly identical genotypes, suggesting that additional genetic factors, possibly gene dosage, or environmental factors are responsible for this diversity.
Copyright © 2014 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved.

Entities:  

Keywords:  Genotype versus phenotype expressions; immunology; immunoreconstitution; intravenous immunoglobulin; newborn screening for severe combined immunodeficiency; primary immunodeficiencies; whole-genome sequencing

Mesh:

Year:  2014        PMID: 24589342      PMCID: PMC3988899          DOI: 10.1016/j.jaci.2014.01.026

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  72 in total

Review 1.  Controversies in IgG replacement therapy in patients with antibody deficiency diseases.

Authors:  Erwin W Gelfand; Hans D Ochs; William T Shearer
Journal:  J Allergy Clin Immunol       Date:  2013-04       Impact factor: 10.793

2.  ζ Chain-associated protein of 70 kDa (ZAP70) deficiency in human subjects is associated with abnormalities of thymic stromal cells: Implications for T-cell tolerance.

Authors:  Pietro Luigi Poliani; Elena Fontana; Chaim M Roifman; Luigi D Notarangelo
Journal:  J Allergy Clin Immunol       Date:  2012-12-14       Impact factor: 10.793

3.  Blood CD4+CD45RO+CXCR5+ T cells are decreased but partially functional in signal transducer and activator of transcription 3 deficiency.

Authors:  Fabienne Mazerolles; Capucine Picard; Sven Kracker; Alain Fischer; Anne Durandy
Journal:  J Allergy Clin Immunol       Date:  2013-02-10       Impact factor: 10.793

4.  Expanding the spectrum of recombination-activating gene 1 deficiency: a family with early-onset autoimmunity.

Authors:  Lauren A Henderson; Francesco Frugoni; Gregory Hopkins; Helen de Boer; Sung-Yun Pai; Yu Nee Lee; Jolan E Walter; Melissa M Hazen; Luigi D Notarangelo
Journal:  J Allergy Clin Immunol       Date:  2013-07-24       Impact factor: 10.793

5.  Cognitive and psychosocial function post hematopoietic stem cell transplantation in children with hemophagocytic lymphohistiocytosis.

Authors:  Jessica Jackson; Penny Titman; Stephen Butler; Kathryn Bond; Anupama Rao; Paul Veys; Robert Chiesa; Alison Leiper; Lynne Riley; Kimberly Gilmour; Persis Amrolia; Kanchan Rao
Journal:  J Allergy Clin Immunol       Date:  2013-08-26       Impact factor: 10.793

6.  Newborn screening for severe combined immunodeficiency and T-cell lymphopenia in California: results of the first 2 years.

Authors:  Antonia Kwan; Joseph A Church; Morton J Cowan; Rajni Agarwal; Neena Kapoor; Donald B Kohn; David B Lewis; Sean A McGhee; Theodore B Moore; E Richard Stiehm; Matthew Porteus; Constantino P Aznar; Robert Currier; Fred Lorey; Jennifer M Puck
Journal:  J Allergy Clin Immunol       Date:  2013-07       Impact factor: 10.793

7.  Aberrant glycosylation of IgA in Wiskott-Aldrich syndrome and X-linked thrombocytopenia.

Authors:  Masaki Shimizu; Hirokazu Kanegane; Taizo Wada; Yaeko Motoyoshi; Tomohiro Morio; Fabio Candotti; Akihiro Yachie
Journal:  J Allergy Clin Immunol       Date:  2012-10-26       Impact factor: 10.793

8.  Elevated IgE and atopy in patients treated for early-onset ADA-SCID.

Authors:  Monica G Lawrence; John S Barber; Robert A Sokolic; Elizabeth K Garabedian; Avanti N Desai; Michelle O'Brien; Nina Jones; Pawan Bali; Michael S Hershfield; Kelly D Stone; Fabio Candotti; Joshua D Milner
Journal:  J Allergy Clin Immunol       Date:  2013-07-26       Impact factor: 10.793

9.  Whole-exome sequencing links caspase recruitment domain 11 (CARD11) inactivation to severe combined immunodeficiency.

Authors:  Johann Greil; Tobias Rausch; Thomas Giese; Obul R Bandapalli; Volker Daniel; Isabelle Bekeredjian-Ding; Adrian M Stütz; Christoph Drees; Susanne Roth; Jürgen Ruland; Jan O Korbel; Andreas E Kulozik
Journal:  J Allergy Clin Immunol       Date:  2013-04-03       Impact factor: 10.793

10.  Autoimmunity in primary antibody deficiency is associated with protein tyrosine phosphatase nonreceptor type 22 (PTPN22).

Authors:  Gary Y J Chew; Umang Sinha; Paul A Gatenby; Theo DeMalmanche; Stephen Adelstein; Roger Garsia; Pravin Hissaria; Martyn A French; Anastasia Wilson; Belinda Whittle; Philippa Kirkpatrick; D Sean Riminton; David A Fulcher; Matthew C Cook
Journal:  J Allergy Clin Immunol       Date:  2012-07-31       Impact factor: 10.793

View more
  3 in total

1.  Fever, pulmonary interstitial fibrosis, and hepatomegaly in a 15-year-old boy with Gaucher disease: a case report.

Authors:  Meng Yang
Journal:  J Med Case Rep       Date:  2018-10-21

Review 2.  Primary immunodeficiency for the primary care provider.

Authors:  A W O'Keefe; M Halbrich; M Ben-Shoshan; C McCusker
Journal:  Paediatr Child Health       Date:  2016-03       Impact factor: 2.253

Review 3.  Clinical applications of gene therapy for primary immunodeficiencies.

Authors:  Maria Pia Cicalese; Alessandro Aiuti
Journal:  Hum Gene Ther       Date:  2015-04       Impact factor: 5.695

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.